A New Side Effect of Intravitreal Dexamethasone Implant (Ozurdex®).
Erdem ErisGurkan ErdoganIrfan PerenteGokhan DemirBurcin Kepez YildizEbru Demet AygitPublished in: Case reports in ophthalmological medicine (2017)
Dexamethasone implant, 0,7 mg (Ozurdex, Allergan, Inc., Irvine, CA, USA), is drug mostly used in the treatment of the diabetic macular edema and edema related to retinal vein occlusion. By reporting this case we aimed to report a new side effect of 0.7 mg intravitreal dexamethasone implant that has not been reported in the literature before.